# E17 General Principles for Planning and Design of Multi-Regional Clinical Trials - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/e17-general-principles-for-planning-and-design-of-multi-regional-clinical-trials/d2fa5bee-ac83-491d-99ad-7c4d046de439

> FDA guidance document: E17 General Principles for Planning and Design of Multi-Regional Clinical Trials. Issue date: July 19, 2018. Get complete insights and analysis.

---

## Details

- Title: E17 General Principles for Planning and Design of Multi-Regional Clinical Trials
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-07-19
- Comment Close Date: 2016-11-08
- Last Changed: 2020-04-29
- Docket Number: <a href="https://www.regulations.gov/docket/2018-15395">2018-15395</a>

## Related Documents

- [Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/adaptive-design-clinical-trials-for-drugs-and-biologics-guidance-for-industry/97c6b6e1-4164-4fbe-8059-b0aa3fd39415)
- [S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals-questions-and-answers/5b838cf4-2c2e-4c10-8a24-439ce4ce61f1)
- [Labeling for Biosimilar Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-products-guidance-for-industry/e13343b3-e9e8-436e-9bcc-ec73cae4d41c)